KYMR Kymera Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 5, 2026
$107,39
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$55,2652 haftanın en düşüğü
$130,0552 haftanın en yükseği
Piyasa Değeri (MRQ)
$8.89B
P/E (TTM)
-33.0
Hisse Başına Kâr (TTM)
$-3.25
Gelir (TTM)
$105M
rozetleriniz
52 Haftlık Aralık
$55–$130
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$139
P/E
-33.0
ROE
-24.2%
Net Kâr Marjı
-285.3%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
KYMR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$107.39
Piyasa Değeri (MRQ)
$8.89B
P/E (TTM)
-33.0
Hisse Başına Kâr (TTM)
$-3.25
Gelir (TTM)
$105M
ROE (TTM)
-24.2%
52 Haftlık Aralık
$55–$130
KYMR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Kymera Therapeutics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
sektörHealthcare
endüstriBiotechnology
çalışanlar273
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$39M2019-12-31 → 2025-12-31
Hisse Başına Kâr$-3.692020-12-31 → 2025-12-31
Serbest Nakit Akışı$-234M2020-12-31 → 2025-12-31
Net kar marjı-285.3%2020-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | KYMR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -33.05Y ort. ≈-16.8 | ≈-16.8 | · | · | |
| F/S (TTM) | 84.75Y ort. ≈72.8 | ≈72.8 | 28.1 | Aşırı değerli | |
| F/D (MRQ) | 5.95Y ort. ≈4.3 | ≈4.3 | 8.1 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -37.45Y ort. ≈-18.4 | ≈-18.4 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -37.65Y ort. ≈-18.7 | ≈-18.7 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 5.55Y ort. ≈4.3 | ≈4.3 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | KYMR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -333.5%5Y ort. ≈-428.0% | ≈-428.0% | -38.2% | Zayıf | |
| FAVÖK Marjı (TTM) | -325.7%5Y ort. ≈-417.8% | ≈-417.8% | -38.2% | Zayıf | |
| Pretax Margin (Vergi Öncesi Kar Marjı) | -794.0% | · | 4.3% | Zayıf | |
| Net Kâr Marjı (TTM) | -285.3%5Y ort. ≈-385.0% | ≈-385.0% | -42.8% | Zayıf | |
| ROA (TTM) | -21.6%5Y ort. ≈-24.1% | ≈-24.1% | -20.7% | Aynı seviyede | |
| ROE (TTM) | -24.2%5Y ort. ≈-27.9% | ≈-27.9% | -22.4% | Aynı seviyede | |
| ROIC | -22.1% | · | -19.6% | Aynı seviyede |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | KYMR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 10.35Y ort. ≈6.7 | ≈6.7 | 8.1 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 4.35Y ort. ≈1.8 | ≈1.8 | 5.0 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | KYMR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -16.7%5Y ort. ≈17.9% | ≈17.9% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -5.7%5Y ort. ≈4.3% | ≈4.3% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 2.9% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | KYMR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.1 | ≈0.1 | 0.1 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$143.6K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.16%
Sonraki Rapor
Kas 02, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 10, 2026 | $-0.62 | $-0.73 | 14.8% |
| 31 Mart 2026 | $-0.71 | $-0.90 | 21.0% | |
| 31 Aralık 2025 | $-0.97 | $-0.81 | -19.4% | |
| 30 Eylül 2025 | $-0.94 | $-0.82 | -14.6% | |
| 30 Haziran 2025 | $-0.95 | $-0.83 | -15.0% | |
| 31 Mart 2025 | $-0.82 | $-0.93 | 12.3% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $39M | $47M | $79M | $47M | $73M | $34M | $3M | |
| Cost of Revenue | $39M | $47M | $79M | $47M | · | · | · | |
| R&D Expense | $317M | $240M | $189M | $164M | $137M | $62M | $37M | |
| SG&A Expense | $68M | $64M | $55M | $44M | $36M | $18M | $8M | |
| Operating Expenses | $389M | $309M | $244M | $208M | $173M | $80M | $45M | |
| Operating Income | $-349M | $-262M | $-166M | $-161M | $-101M | $-46M | $-42M | |
| Other Non-op | $38M | $38M | $19M | $6M | $313.0K | $711.0K | $959.0K | |
| Pretax Income | $-311M | · | · | · | · | · | · | |
| Income Tax | $0 | · | · | $0 | $0 | $0 | $0 | |
| Net Income | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | $-41M | |
| EPS (Basic) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| EPS (Diluted) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| Shares (Basic) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| Shares (Diluted) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| EBITDA | $-341M | $-254M | $-162M | $-158M | $-98M | $-45M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $357M | $120M | $110M | $68M | $48M | $31M | $76M | |
| Receivables | $0 | $0 | $15M | $0 | · | · | · | |
| Prepaid Expense | $23M | $22M | $12M | $10M | $9M | $5M | $888.0K | |
| Current Assets | $871M | $510M | $405M | $419M | $451M | $302M | $93M | |
| PP&E (Net) | $43M | $50M | $48M | $13M | $12M | $11M | $4M | |
| PP&E (Gross) | $65M | $67M | $59M | $20M | $16M | $13M | $5M | |
| Accum. Depreciation | $22M | $16M | $10M | $7M | $4M | $2M | $1M | |
| Other Non-current Assets | $9M | $2M | $2M | $3M | $2M | $30.0K | $2M | |
| Total Assets | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Accounts Payable | $4M | $6M | $7M | $4M | $4M | $4M | $3M | |
| Accrued Liabilities | $42M | $35M | $34M | $28M | $23M | $10M | $5M | |
| Current Liabilities | $83M | $68M | $86M | $71M | $93M | $111M | $35M | |
| Capital Leases | $67M | $72M | $77M | $12M | $13M | $14M | $17M | |
| Other Non-current Liabilities | · | $0 | $0 | $248.0K | $66.0K | $100.0K | · | |
| Total Liabilities | $163M | $142M | $181M | $113M | $146M | $203M | $82M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | · | |
| Retained Earnings | $-1.07B | $-755M | $-531M | $-384M | $-229M | $-129M | $-76M | |
| AOCI | $2M | $-1M | $-552.0K | $-5M | $-660.0K | $-128.0K | $6.0K | |
| Stockholders' Equity | $1.58B | $836M | $395M | $490M | $460M | $284M | $-74M | |
| Liabilities + Equity | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Shares Outstanding | 81,323,532 | 64,890,193 | 55,585,305 | 55,039,380 | 51,536,181 | 44,482,186 | 1,929,516 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $7M | $4M | $3M | $2M | $2M | $825.0K | |
| Stock-based Comp | $60M | $55M | $43M | $35M | $25M | $5M | $1M | |
| Other Non-cash | $10M | $-33M | $-3M | $-37M | $-56M | $127M | · | |
| Operating Cash Flow | $-233M | $-195M | $-103M | $-153M | $-129M | $88M | $18M | |
| CapEx | $1M | $13M | $34M | $3M | $2M | $9M | $532.0K | |
| Investing Cash Flow | $-521M | $-404M | $140M | $21M | $-100M | $-423M | $-16M | |
| Financing Cash Flow | $991M | $609M | $4M | $153M | $250M | $289M | $35M | |
| Net Change in Cash | $237M | $10M | $41M | $20M | $21M | $-45M | $36M | |
| Free Cash Flow | $-234M | $-207M | $-137M | $-156M | $-131M | $79M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% | -136.1% | · | |
| Net Margin | -794.0% | -475.6% | -187.0% | -330.6% | -137.6% | -134.0% | · | |
| Pretax Margin | -794.0% | · | · | · | · | · | · | |
| EBITDA Margin | -869.9% | -540.2% | -206.1% | -338.0% | -134.7% | -130.9% | · | |
| ROA | -22.9% | -28.8% | -24.9% | -25.6% | -18.3% | -15.1% | · | |
| ROE | -24.4% | -25.9% | -37.2% | -30.9% | -21.3% | -15.8% | · | |
| ROIC | -22.1% | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 | 2.7 | · | |
| Quick Ratio | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 | 0.3 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | 6.3 | 10.5 | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $19.42 | $12.88 | · | $8.91 | $8.92 | $6.38 | · | |
| Revenue / Share | $0.46 | $0.63 | $1.35 | $0.87 | · | · | · | |
| Cash Flow / Share | $-2.76 | $-2.59 | $-1.76 | $-2.84 | · | · | · | |
| Cash / Share | $4.39 | $1.85 | · | $1.24 | $0.93 | $0.70 | · | |
| EPS (TTM) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -16.7% | -40.1% | 67.8% | -35.7% | 114.0% | · | · | |
| Revenue CAGR 3Y | -5.7% | -13.5% | 32.2% | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $39M | $47M | $79M | $47M | $73M | $34M | · | |
| Net Income TTM | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | · | |
| Market Cap | $6.33B | $2.61B | · | $1.37B | $3.27B | $2.76B | · | |
| P/E | -21.1 | -13.5 | -10.1 | -8.7 | -30.4 | -19.7 | · | |
| P/S | 161.4 | 55.5 | · | 29.3 | 44.9 | 81.0 | · | |
| P/B | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Tangible Book | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Cash Flow | -27.2 | -13.4 | · | -9.0 | -25.4 | 31.3 | · | |
| P / FCF | -27.0 | -12.6 | · | -8.8 | -25.1 | 34.9 | · | |
| Earnings Yield | -4.7% | -7.4% | -9.9% | -11.5% | -3.3% | -5.1% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | $48M | $5M | $17M | $9M | $16M | $10M | |
| Cost of Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | · | · | · | · | · | · | |
| R&D Expense | $119M | $98M | $84M | $74M | $78M | $80M | $72M | $60M | $59M | $49M | $53M | $48M | $46M | $42M | $43M | $44M | |
| SG&A Expense | $21M | $20M | $17M | $17M | $18M | $16M | $16M | $15M | $17M | $14M | $14M | $14M | $14M | $13M | $12M | $11M | |
| Operating Expenses | $141M | $119M | $101M | $95M | $96M | $97M | $88M | $76M | $77M | $68M | $67M | $62M | $60M | $55M | $55M | $54M | |
| Operating Income | $-76M | $-84M | $-98M | $-93M | $-85M | $-74M | $-81M | $-72M | $-51M | $-58M | $-19M | $-58M | $-43M | $-45M | $-39M | $-45M | |
| Other Non-op | $14M | $15M | $11M | $10M | $8M | $9M | $10M | $10M | $9M | $9M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $100.0K | $0 | · | $0 | |
| Net Income | $-61M | $-69M | $-87M | $-82M | $-77M | $-66M | $-71M | $-62M | $-42M | $-49M | $-14M | $-53M | $-39M | $-41M | $-35M | $-43M | |
| EPS (Basic) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| EPS (Diluted) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| Shares (Basic) | 98,177,158 | 97,534,269 | · | 87,300,286 | 80,449,405 | 80,146,531 | · | 76,125,975 | 73,059,398 | 70,770,320 | · | 58,421,859 | 58,326,963 | 58,187,038 | · | 54,535,514 | |
| Shares (Diluted) | 98,177,158 | 97,534,269 | · | 87,300,286 | 80,449,405 | 80,146,531 | · | 76,125,975 | 73,059,398 | 70,770,320 | · | 58,421,859 | 58,326,963 | 58,187,038 | · | 54,535,514 | |
| EBITDA | $-76M | $-82M | · | $-93M | $-85M | $-72M | · | $-72M | $-51M | $-56M | · | $-58M | $-43M | $-44M | · | $-45M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $124M | $144M | $357M | $113M | $336M | $90M | $120M | $111M | $68M | $94M | $110M | $81M | $52M | $50M | $68M | $156M | |
| Receivables | $20M | · | · | · | $40M | · | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $26M | $27M | $23M | $23M | $23M | $18M | $22M | $17M | $14M | $15M | · | $14M | $14M | $11M | · | $9M | |
| Current Assets | $737M | $677M | $871M | $528M | $728M | $501M | $510M | $569M | $525M | $537M | · | $376M | $385M | $412M | · | $494M | |
| PP&E (Net) | $40M | $42M | $43M | $45M | $49M | $49M | $50M | $51M | $52M | $49M | · | $36M | $27M | $17M | · | $13M | |
| PP&E (Gross) | $66M | $66M | $65M | $67M | $69M | $67M | $67M | $65M | $64M | $60M | · | $46M | $36M | $25M | · | $19M | |
| Accum. Depreciation | $26M | $24M | $22M | $22M | $20M | $18M | $16M | $14M | $12M | $11M | · | $10M | $9M | $8M | · | $6M | |
| Other Non-current Assets | $7M | $8M | $9M | $7M | $5M | $3M | $2M | $0 | $2M | $2M | · | $3M | $3M | $3M | · | $3M | |
| Total Assets | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Accounts Payable | $9M | $13M | $4M | $6M | $6M | $10M | $6M | $6M | $7M | $7M | · | $5M | $4M | $6M | · | $6M | |
| Accrued Liabilities | $48M | $35M | $42M | $29M | $28M | $23M | $35M | $27M | $24M | $16M | · | $26M | $22M | $19M | · | $25M | |
| Current Liabilities | $71M | $63M | $83M | $72M | $88M | $59M | $68M | $67M | $62M | $56M | · | $63M | $55M | $62M | · | $91M | |
| Capital Leases | $64M | $66M | $67M | $68M | $70M | $71M | $72M | $74M | $75M | $76M | · | $77M | $71M | $64M | · | $12M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $8.0K | $230.0K | $237.0K | · | $256.0K | |
| Total Liabilities | $136M | $129M | $163M | $156M | $160M | $132M | $142M | $142M | $141M | $157M | · | $157M | $147M | $152M | · | $126M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $-1.20B | $-1.14B | $-1.07B | $-979M | $-897M | $-820M | $-755M | $-684M | $-621M | $-579M | · | $-516M | $-464M | $-425M | · | $-349M | |
| AOCI | $-7M | $-4M | $2M | $2M | $279.0K | $-58.0K | $-1M | $2M | $-2M | $-2M | · | $-2M | $-4M | $-3M | · | $-6M | |
| Stockholders' Equity | $1.51B | $1.54B | $1.58B | $946M | $971M | $786M | $836M | $893M | $685M | $711M | $395M | $396M | $435M | $462M | $490M | $513M | |
| Liabilities + Equity | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Shares Outstanding | 82,788,253 | 82,182,101 | 81,323,532 | 71,741,174 | 70,557,442 | 65,112,714 | 64,890,193 | 64,748,226 | 61,572,383 | 61,353,146 | · | 55,450,239 | 55,390,259 | 55,276,226 | · | 54,751,429 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $891.0K | $895.0K | $900.0K | $879.0K | $818.0K | $767.0K | |
| Stock-based Comp | $19M | $16M | $14M | $16M | $15M | $14M | $14M | $15M | $14M | $12M | $11M | $12M | $11M | $9M | $9M | $9M | |
| Other Non-cash | · | $-38M | · | · | · | $-30M | · | · | · | $-4M | · | · | · | $-13M | · | · | |
| Operating Cash Flow | $-54M | $-89M | $-67M | $-27M | $-60M | $-79M | $-62M | $-50M | $-43M | $-40M | $8M | $-32M | $-35M | $-44M | $-40M | $-34M | |
| CapEx | $473.0K | $434.0K | $106.0K | $181.0K | $695.0K | $467.0K | $936.0K | $-189.0K | $5M | $7M | $12M | $8M | $11M | $4M | $373.0K | $1M | |
| Investing Cash Flow | $20M | $-143M | $-394M | $-235M | $60M | $49M | $69M | $-158M | $16M | $-331M | $19M | $61M | $36M | $25M | $-50M | $-37M | |
| Financing Cash Flow | $14M | $19M | $705M | $40M | $246M | $258.0K | $3M | $251M | $1M | $354M | $2M | $-206.0K | $1M | $1M | $2M | $150M | |
| Net Change in Cash | $-20M | $-213M | $244M | $-223M | $246M | $-30M | $10M | $43M | $-26M | $-16M | $29M | $29M | $2M | $-18M | $-87M | $79M | |
| Free Cash Flow | · | $-89M | · | · | · | $-80M | · | · | · | $-47M | · | · | · | $-48M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -116.3% | -244.9% | · | -3347.4% | -736.8% | -336.8% | · | -1927.9% | -198.5% | -562.2% | · | -1216.4% | -262.7% | -478.8% | · | -469.9% | |
| Net Margin | -94.2% | -201.5% | · | -2973.0% | -667.6% | -296.8% | · | -1670.3% | -164.0% | -472.0% | · | -1118.2% | -235.0% | -432.4% | · | -450.2% | |
| EBITDA Margin | -116.3% | -239.0% | · | -3347.4% | -736.8% | -327.5% | · | -1927.9% | -198.5% | -548.0% | · | -1216.4% | -262.7% | -469.5% | · | -469.9% | |
| ROA | -4.4% | -5.3% | · | -7.7% | -7.8% | -7.3% | · | -7.9% | -6.0% | -6.6% | · | -8.9% | -7.0% | -7.0% | · | -6.7% | |
| ROE | -4.9% | -5.9% | · | -8.9% | -9.2% | -8.8% | · | -9.7% | -7.5% | -8.3% | · | -11.6% | -9.3% | -9.2% | · | -8.6% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 10.8 | · | 7.4 | 8.3 | 8.5 | · | 8.5 | 8.5 | 9.6 | · | 5.9 | 7.1 | 6.6 | · | 5.4 | |
| Quick Ratio | 2.0 | 2.3 | · | 1.6 | 4.3 | 1.5 | · | 1.7 | 1.1 | 1.7 | · | 1.3 | 1.0 | 0.8 | · | 1.7 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 2.2 | · | · | · | 0.6 | · | · | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $18.23 | $18.73 | · | $13.19 | $13.77 | $12.07 | · | $13.79 | $11.12 | $11.59 | · | $7.13 | $7.86 | $8.36 | · | $9.37 | |
| Revenue / Share | $0.66 | $0.35 | · | $0.03 | $0.14 | $0.28 | · | $0.05 | $0.35 | $0.15 | · | $0.08 | $0.28 | $0.16 | · | $0.18 | |
| Cash Flow / Share | · | $-0.91 | · | · | · | $-0.99 | · | · | · | $-0.56 | · | · | · | $-0.76 | · | · | |
| Cash / Share | $1.50 | $1.75 | · | $1.57 | $4.76 | $1.38 | · | $1.71 | $1.10 | $1.52 | · | $1.46 | $0.95 | $0.91 | · | $2.84 | |
| EPS (TTM) | $-3.25 | $-3.58 | · | $-3.60 | $-3.48 | $-3.11 | · | $-2.34 | $-2.42 | $-2.51 | · | $-2.86 | $-2.75 | $-2.86 | · | $-2.95 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $105M | $51M | · | $44M | $45M | $59M | · | $88M | $89M | $79M | · | $47M | $52M | $47M | · | $46M | |
| Net Income TTM | $-300M | $-315M | · | $-295M | $-275M | $-241M | · | $-167M | $-158M | $-155M | · | $-167M | $-158M | $-159M | · | $-154M | |
| Market Cap | $9.49B | $6.84B | · | $4.06B | $3.08B | $1.78B | · | $3.06B | $1.84B | $2.47B | · | $771M | $1.27B | $1.64B | · | $1.19B | |
| P/E | -35.3 | -23.3 | · | -15.7 | -12.5 | -8.8 | · | -20.2 | -12.3 | -16.0 | · | -4.9 | -8.4 | -10.4 | · | -7.4 | |
| P/S | 90.4 | 133.0 | · | 92.8 | 68.9 | 30.3 | · | 35.0 | 20.8 | 31.1 | · | 16.5 | 24.6 | 35.1 | · | 25.9 | |
| P/B | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Tangible Book | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Cash Flow | · | -77.0 | · | · | · | -22.5 | · | · | · | -62.3 | · | · | · | -37.3 | · | · | |
| Earnings Yield | -2.8% | -4.3% | · | -6.4% | -8.0% | -11.4% | · | -4.9% | -8.1% | -6.2% | · | -20.6% | -12.0% | -9.7% | · | -13.6% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $39M | $47M | $79M | $47M | $73M |
| Faaliyet Kâr Marjı % | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% |
| Net Gelir | $-311M | $-224M | $-147M | $-155M | $-100M |
| Seyreltilmiş Hisse Başı Kâr | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 |
| Cari Oran | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-234M | $-207M | $-137M | $-156M | $-131M |
Kurumsal Sahipler (13F) 305 dosya · $10.2B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
305
Tutulan Değer
$10.2B
Yeni pozisyonlar
53
Çıkan pozisyonlar
23
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 53 (+7 önceki Ç'ye göre) | 23 (-13 önceki Ç'ye göre) | 101 (+5 önceki Ç'ye göre) | 80 (+8 önceki Ç'ye göre) | +431K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| FMR LLC | $1.416.089.213 | 12.349.256 | 13,95% | Hisse senetleri |
| BAKER BROS. ADVISORS LP | $992.725.940 | 8.657.242 | 9,78% | Hisse senetleri |
| Avoro Capital Advisors LLC | $857.129.238 | 7.474.747 | 8,44% | Hisse senetleri |
| BlackRock, Inc. | $635.066.535 | 5.538.210 | 6,25% | Hisse senetleri |
| VANGUARD GROUP INC | $487.685.380 | 6.267.644 | 4,80% | Hisse senetleri |
| BVF INC/IL | $444.008.203 | 3.872.052 | 4,37% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $421.415.461 | 3.675.028 | 4,15% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $343.114.771 | 2.992.193 | 3,38% | Hisse senetleri |
| Siren, L.L.C. | $336.651.626 | 2.935.830 | 3,32% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $336.255.785 | 2.932.378 | 3,31% | Hisse senetleri |
| Atlas Venture Life Science Advisors, LLC | $326.527.526 | 2.847.541 | 3,22% | Hisse senetleri |
| STATE STREET CORP | $313.877.705 | 2.737.226 | 3,09% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $208.316.264 | 1.816.331 | 2,05% | Hisse senetleri |
| Capital Research Global Investors | $159.262.984 | 1.388.881 | 1,57% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $136.151.475 | 1.187.333 | 1,34% | Hisse senetleri |
| UBS Group AG | $115.561.789 | 1.007.777 | 1,14% | Hisse senetleri |
| Driehaus Capital Management LLC | $105.408.448 | 919.233 | 1,04% | Hisse senetleri |
| Merck & Co., Inc. | $88.544.161 | 772.165 | 0,87% | Hisse senetleri |
| NORGES BANK | $86.833.399 | 757.246 | 0,86% | Hisse senetleri |
| FEDERATED HERMES, INC. | $85.933.469 | 749.398 | 0,85% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $85.421.500 | 745.152 | 0,84% | Hisse senetleri |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $84.955.104 | 740.866 | 0,84% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $81.750.884 | 981.521 | 0,81% | Hisse senetleri |
| Holocene Advisors, LP | $72.996.514 | 636.579 | 0,72% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $72.951.379 | 875.872 | 0,72% | Hisse senetleri |
| NORTHERN TRUST CORP | $66.727.276 | 581.907 | 0,66% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60.744.024 | 529.729 | 0,60% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $59.060.783 | 515.050 | 0,58% | Hisse senetleri |
| EVENTIDE ASSET MANAGEMENT, LLC | $57.811.287 | 504.210 | 0,57% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $57.676.487 | 502.978 | 0,57% | Hisse senetleri |
| Woodline Partners LP | $57.434.534 | 500.868 | 0,57% | Hisse senetleri |
| Rock Springs Capital Management LP | $51.963.399 | 453.156 | 0,51% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $51.570.654 | 449.731 | 0,51% | Hisse senetleri |
| Boxer Capital Management, LLC | $49.204.897 | 429.100 | 0,48% | Hisse senetleri |
| Pictet Asset Management Holding SA | $44.984.008 | 395.540 | 0,44% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $43.378.055 | 378.286 | 0,43% | Hisse senetleri |
| BRAIDWELL LP | $43.363.951 | 378.163 | 0,43% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $43.100.784 | 375.868 | 0,42% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $42.585.457 | 371.374 | 0,42% | Hisse senetleri |
| Clearbridge Investments, LLC | $39.815.871 | 347.221 | 0,39% | Hisse senetleri |
| Octagon Capital Advisors LP | $35.547.700 | 310.000 | 0,35% | Hisse senetleri |
| Nextech Invest Ltd. | $31.981.004 | 278.896 | 0,31% | Hisse senetleri |
| Alyeska Investment Group, L.P. | $31.701.095 | 276.455 | 0,31% | Hisse senetleri |
| TD Asset Management Inc | $31.293.443 | 272.900 | 0,31% | Hisse senetleri |
| VOYA INVESTMENT MANAGEMENT LLC | $30.951.039 | 269.914 | 0,30% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $29.085.378 | 373.800 | 0,29% | Hisse senetleri |
| Commodore Capital LP | $28.667.500 | 250.000 | 0,28% | Hisse senetleri |
| RTW INVESTMENTS, LP | $27.520.800 | 240.000 | 0,27% | Hisse senetleri |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $26.799.869 | 233.713 | 0,26% | Hisse senetleri |
| GILDER GAGNON HOWE & CO LLC | $26.265.508 | 229.053 | 0,26% | Hisse senetleri |
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N, Hrustanovic Gorjan ×2 başvurular | 26 Haziran 2026 | 6,30% | Değişiklik | · | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×4 başvurular | 11 Aralık 2025 | 10,90% | Değişiklik | Sermaye yapısı | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, GORJAN HRUSTANOVIC ×5 başvurular | 09 Ocak 2024 | · | İlk başvuru | · | SEC |
| Vertex Pharmaceuticals Incorporated ×2 başvurular | 05 Haziran 2023 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 25 içeriden öğrenenler · 10 yöneticiler · 13 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Nello Mainolfi | Chief Executive Officer | 01 Ekim 2026 M | 666.568 | 0 | 26 | $-36.819.541 |
| Bruce N. Jacobs | Chief Financial Officer | 30 Haziran 2026 M | 244.883 | 0 | 15 | $-9.956.105 |
| Jeremy G Chadwick | Chief Operating Officer | 27 Mayıs 2026 S | 44.018 | 0 | 29 | $-15.599.618 |
| Brian Adams | Chief Legal Officer | 04 Eylül 2026 S | 50.254 | 0 | 3 | $-744.297 |
| Terence Rooney | Chief Medical Officer | 27 Temmuz 2026 A | 38.000 | 0 | 0 | $0 |
| Noah Goodman | Chief Business Officer | 01 Temmuz 2026 S | 47.179 | 0 | 9 | $-2.223.845 |
| Jared Gollob | Chief Medical Officer | 02 Mart 2026 A | 117.134 | 0 | 18 | $-9.134.491 |
| Ellen Chiniara | Chief Legal Officer | 03 Mart 2025 A | 80.085 | 0 | 0 | $0 |
| Elaine Caughey | Chief Business Officer | 01 Mart 2023 A | 18.986 | 0 | 0 | $0 |
| Richard Chesworth | Chief Scientific Officer | 27 Ağustos 2021 M | 0 | 0 | 0 | $0 |
| Bruce Booth | Yönetim kurulu üyesi | 29 Haziran 2026 S | 462.856 | 0 | 160 | $-226.031.370 |
| Hrustanovic Gorjan | Yönetim kurulu üyesi | 24 Haziran 2026 A | · | 0 | 0 | $0 |
| Elena Ridloff | Yönetim kurulu üyesi | 24 Haziran 2026 A | 0 | 0 | 4 | $-1.285.644 |
| Pamela Esposito | Yönetim kurulu üyesi | 24 Haziran 2026 A | 1.000 | 0 | 12 | $-3.054.174 |
| Jeffrey W. Albers | Yönetim kurulu üyesi | 24 Haziran 2026 A | 0 | 0 | 3 | $-744.757 |
| Victor Sandor | Yönetim kurulu üyesi | 24 Haziran 2026 A | · | 0 | 0 | $0 |
| John Maraganore | Yönetim kurulu üyesi | 24 Haziran 2026 A | · | 0 | 0 | $0 |
| Leigh Morgan | Yönetim kurulu üyesi | 18 Haziran 2024 A | · | 0 | 0 | $0 |
| Joanna Horobin | Yönetim kurulu üyesi | 07 Haziran 2024 M | 0 | 0 | 0 | $0 |
| Donald William Nicholson | Yönetim kurulu üyesi | 15 Haziran 2022 A | · | 0 | 0 | $0 |
| Steven Edward Hall | Yönetim kurulu üyesi | 25 Ağustos 2020 C | 2.192.249 | 0 | 0 | $0 |
| Andrew Hedin | Yönetim kurulu üyesi | 20 Ağustos 2020 A | · | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | 10% sahip | 18 Mayıs 2021 J | 5.763.012 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% sahip | 25 Ağustos 2020 C | 959.211 | 0 | 0 | $0 |
| Alexandria Venture Investments, LLC | 10% sahip | 25 Ağustos 2020 C | 467.932 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 49 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| HAPS · Harbor ETF Trust | 2,21% | 36.388 NS | 31 Temmuz 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,75% | 45.819 SH | 02 Ekim 2026 | Günlük |
| GURU · Global X Funds | 1,41% | 8.375 NS | 31 Temmuz 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,90% | 43.133 NS | 31 Temmuz 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,80% | 3.605 NS | 31 Temmuz 2026 | N-PORT |
| IBB · iShares Trust | 0,62% | 543.907 SH | 11 Eylül 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,61% | 5.875 SH | 02 Ekim 2026 | Günlük |
| ESSC · Strategy Shares | 0,44% | 1.522 NS | 31 Temmuz 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,43% | 24.014 NS | 31 Temmuz 2026 | N-PORT |
| IWO · iShares Trust | 0,40% | 487.324 SH | 11 Eylül 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,35% | 55.351 SH | 19 Ağustos 2026 | Günlük |
| PWS · Pacer Funds Trust | 0,25% | 589 NS | 31 Temmuz 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,25% | 2.092 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,24% | 1.600.729 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,22% | 360.394 SH | 19 Ağustos 2026 | Günlük |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 14.574 NS | 31 Temmuz 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,21% | 871.540 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,21% | 29.987 NS | 31 Temmuz 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,19% | 32.324 SH | 19 Ağustos 2026 | Günlük |
| FFSM · FIDELITY COVINGTON TRUST | 0,18% | 25.352 NS | 31 Temmuz 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,14% | 17.965 NS | 31 Temmuz 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,13% | 7.208 NS | 31 Temmuz 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,10% | 152.728 NS | 31 Temmuz 2026 | N-PORT |
| ISCG · iShares Trust | 0,10% | 8.361 SH | 11 Eylül 2026 | Günlük |
| ESML · iShares Trust | 0,09% | 22.280 SH | 11 Eylül 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,09% | 1.509.269 SH | 19 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 19.721 SH | 02 Ekim 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,08% | 726.357 SH | 19 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,08% | 9.461 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,08% | 134.854 SH | 19 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,07% | 21.341 NS | 31 Temmuz 2026 | N-PORT |
| WSML · iShares Trust | 0,06% | 3.284 SH | 11 Eylül 2026 | Günlük |
| FBCG · FIDELITY COVINGTON TRUST | 0,05% | 31.560 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 113.415 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 5.280 NS | 31 Temmuz 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3.058 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 15.117 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 2.447 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 2.089.726 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 49.584 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 5.163 SH | 19 Ağustos 2026 | Günlük |
| ITOT · iShares Trust | 0,01% | 81.928 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,01% | 17.103 SH | 11 Eylül 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,01% | 13.837 SH | 19 Ağustos 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,00% | 9.292 NS | 31 Temmuz 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 151 NS | 31 Temmuz 2026 | N-PORT |
| IWN · iShares Trust | · | 102.204 SH | 11 Eylül 2026 | Günlük |
| ISCB · iShares Trust | · | 2.398 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 6.014 SH | 11 Eylül 2026 | Günlük |
KYMR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 30 analist
AL
Medyan hedef
$135.50
+26,2%
10 33,3%
Güçlü Al
16 53,3%
Al
4 13,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
22 analist · 2026-10-04Ortalama hedef $138.64 +29,1%
← Tüm hedeflerin altında
Mevcut fiyat $107.39
Düşük$111.00
Ortalama$138.64
Yüksek$180.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | · |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | · |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | · |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | · |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | · |
| PCVX | $6.05B | -8.2 | · | · | -26.6% | · |
| TGTX | $4.63B | 10.8 | 87.3% | 72.6% | 96.7% | · |
| PRAX | $7.43B | -21.9 | 249.5% | · | -47.3% | · |
| SYRE | $2.56B | 10.1 | -62.0% | · | -26.5% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 5, 2026